Targeting mutant fibroblast growth factor receptors in cancer
- 15 March 2011
- journal article
- review article
- Published by Elsevier in Trends in Molecular Medicine
- Vol. 17 (5), 283-292
- https://doi.org/10.1016/j.molmed.2011.01.012
Abstract
No abstract availableKeywords
This publication has 108 references indexed in Scilit:
- The landscape of somatic copy-number alteration across human cancersNature, 2010
- Integrative molecular profiling of triple negative breast cancers identifies amplicon drivers and potential therapeutic targetsOncogene, 2010
- Activating mutations in FGFR3 and HRAS reveal a shared genetic origin for congenital disorders and testicular tumorsNature Genetics, 2009
- Mutant fibroblast growth factor receptor 3 induces intracellular signaling and cellular transformation in a cell type- and mutation-specific mannerOncogene, 2009
- Somatic mutations affect key pathways in lung adenocarcinomaNature, 2008
- Comprehensive genomic characterization defines human glioblastoma genes and core pathwaysNature, 2008
- A Molecular Brake in the Kinase Hinge Region Regulates the Activity of Receptor Tyrosine KinasesMolecular Cell, 2007
- Genome-wide association study identifies novel breast cancer susceptibility lociNature, 2007
- A genome-wide association study identifies alleles in FGFR2 associated with risk of sporadic postmenopausal breast cancerNature Genetics, 2007
- Knockdown by shRNA identifies S249C mutant FGFR3 as a potential therapeutic target in bladder cancerOncogene, 2007